Petraglia F

No ORCID on file · 108 papers in corpus
observational 2024
Maturitas ·doi:10.1016/j.maturitas.2024.107996

OBJECTIVES: To explore the imaging features and the molecular characterization of adenomyosis after menopause. STUDY DESIGN: An observational cross-sectional study was performed in a group of postmenopausal patients undergoing a transvagin…

observational 2024
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2024.2336121

BACKGROUND: Dienogest (DNG) improves endometriosis-associated pain (EAP) and patients' quality of life; however, the modern cornerstone of the management of endometriosis is the long-term adherence of the patient to medical treatment. OBJE…

other 2024
Human Reproduction ·doi:10.1093/humrep/deae223
lab-animal 2024
Nature communications ·doi:10.1038/s41467-024-54486-6

Over 60% of women with endometriosis experience abdominopelvic pain and broader pain manifestations, including chronic back pain, fibromyalgia, chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinflammatory mediators, …

lab-animal 2024
·doi:10.21203/rs.3.rs-4045626/v1

Abstract Over 60% of women with endometriosis experience abdominopelvic pain alongside pain in other areas of the body, such as chronic back pain, fibromyalgia and chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinf…

other 2024
F&S science ·doi:10.1016/j.xfss.2024.06.006

Recognizing the limited information, vague diagnostic criterion, and difficult clinical challenges posed by adenomyosis, the Society of Endometriosis and Uterine Disorders organized an expert symposium to present the current understanding o…

lab-animal 2024
The FEBS journal ·doi:10.1111/febs.17071

Endometriosis is a chronic gynecological syndrome characterized by endometrial cell invasion of the extra-uterine milieu, pelvic pain and infertility. Treatment relies on either symptomatic drugs or hormonal therapies, even though the mecha…

review 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.04.041

Uterine fibroids (UFs) are the most common female benign pelvic tumors, affecting >60% of patients aged 30-44 years. Uterine fibroids are asymptomatic in a large percentage of cases and may be identified incidentally using a transvaginal ul…

observational 2023
F1000Research ·doi:10.12688/f1000research.141537.1

BACKGROUND: Sexual health is a major concern in women with endometriosis, however only a few controlled studies have examined this with validated instruments. The effect of hormonal treatments on sexual function in endometriosis is also an …

observational 2023
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2023.03.020

RESEARCH QUESTION: Women with endometriosis are frequently affected by headache. How many of these have a clear diagnosis of migraine? Are the different forms of migraine related to the phenotypes and/or characteristics of endometriosis? D…

review 2023
Vitamins and hormones ·doi:10.1016/bs.vh.2023.01.007

Endometriosis is a benign gynecological disease affecting ∼10% of reproductive-aged women and is defined as the presence of endometrial glands and stroma outside the uterine cavity. Endometriosis can cause a variety of health problems, from…

other 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.12.007

OBJECTIVE: To study the molecular mechanisms responsible for fibrosis in endometriosis by investigating whether the protein expression levels of sphingosine-1-phosphate receptor 3 (S1PR3), one of the five specific receptors of the bioactive…

other 2023
The journal of sexual medicine ·doi:10.1093/jsxmed/qdad004

Journal Article The challenge of endometriosis for female sexual health Get access Silvia Vannuccini, MD, PhD, Silvia Vannuccini, MD, PhD Obstetrics and Gynecology, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy Sear…

review 2022
Current opinion in pharmacology ·doi:10.1016/j.coph.2022.102311

In the past, the primary approach for the treatment of endometriosis was represented by surgery; however, after the introduction of non-invasive diagnosis of endometriosis with the development of imaging technologies, medical treatment beca…

review 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.08.850

Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent among women across their life span, especially during the reproductive age. An iron-deficient state has been associated with a number of adverse health consequences,…

observational 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2047172

OBJECTIVE: To evaluate the different effects of a progestin-only contraceptive with desogestrel (DSG) vs combined oral contraceptives (COCs) for a first line long-term treatment of endometriosis-related pain among patients seeking hormonal …

observational 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.807880

Background: In women with rheumatic diseases (RDs) menstruation-related disorders have never been investigated. The aim of this study was to evaluate gynecological symptoms/disorders in fertile age women with RDs. Materials and methods: All…

review 2022
Minerva obstetrics and gynecology ·doi:10.23736/s2724-606x.22.05157-0

Estrogen dependence and progesterone resistance play a crucial role in the origin and development of endometriosis. Therefore, hormonal therapies are currently the most effective treatment. Progestins are considered the first-line approach,…

other 2022
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2022.03.026

RESEARCH QUESTION: Is sphingosine 1-phosphate (S1P) pathway involved in the process of fibrosis in adenomyosis? DESIGN: RNA was extracted from paraffin-embedded slices collected from the ectopic endometrium of patients with nodular adenomy…

meta-analysis 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00818-6

To investigate the impact of uterine adenomyosis on in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) clinical outcomes and also to evaluate the impact of gonadotropin-releasing hormone agonist (GnRHa) and surgical treatm…

observational 2022
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2022.07.004

STUDY OBJECTIVE: To investigate the clinical and surgical predictors of urinary tract endometriosis (UTE) relapse. DESIGN: Retrospective single institutional study. SETTING: Italian multidisciplinary referral center for endometriosis. PA…

observational 2021
Scientific reports ·doi:10.1038/s41598-021-98336-7

Female sexual dysfunction (FSD) may be a mirror of a poor cardiometabolic state. In a small pilot study enrolling 71 women with FSD, we previously demonstrated that clitoral Pulsatility Index (PI) evaluated by using color Doppler ultrasound…

review 2021
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2021.1878134

Primary dysmenorrhea (PD) is the most common gynecologic disorder during adolescence and it is characterized by crampy lower abdominal pain that occurs during menstruation. Secondary dysmenorrhea, in contrast, has the same clinical features…

observational 2021
Human fertility (Cambridge, England) ·doi:10.1080/14647273.2021.1919764

The relationship between endometriosis and subclinical atherosclerosis represents an emerging topic in women's health, as women with endometriosis are at higher risk of cardiovascular disease later in life. We investigated metabolic paramet…

other 2021
Minerva obstetrics and gynecology ·doi:10.23736/s2724-606x.21.04757-2

INTRODUCTION: The relationship between endometrioma and ovarian cancer is a topic of discussion in the field of endometriosis and to date it is still debated whether ovarian endometriosis may represent a risk factor for ovarian cancers. EV…